Private equity firms back PCI Pharma in bet on drug production
BioPharma Drive: Drug Pricing
JULY 14, 2025
XH4D via Getty Images A group of private equity firms are pouring funding into PCI Pharma Services, betting the contract drug development and manufacturing organization’s business is poised to grow in the years ahead. That funding was supported by a “significant reinvestment” from current backer Mubadala Investment Co.
Let's personalize your content